SCYNEXIS, Inc. is a pharmaceutical company that develops antifungal medicines. Its main product is an oral treatment for vaginal yeast infections, and it also works on antifungal therapies for other serious fungal conditions. The company serves patients and healthcare providers through prescription medicines, and it is based in the United States. Its work centres on drug discovery and clinical development of compounds that address fungal disease.
The shares are listed on the London Exchange in UK under the code 0L49, and the price on this page is in US dollars (USD). Our records, which start in 2019, show no dividend payments for it. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Market X-Ray · price-based
Weak price profile
Ranks #2291 of 3787 on the London Exchange · confidence High
What this score is, and is not
It describes how this stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is. That fundamental X-Ray needs financial statements, which we do not have for UK yet.
TrendStrong
72/100
Trading above its long-term averages and near its highs.
See the numbers →
Above 200-day average35.2%
From 52-week high-38.7%
MomentumStrong
71/100
Rising faster than most stocks on this exchange.
See the numbers →
3-month return-20.2%
6-month return260.8%
12-month, skipping last month507.5%
Stability (higher is calmer)Weak
16/100
Volatile, with deep drawdowns.
See the numbers →
Volatility, 1 year (lower is calmer)217.7%
Worst drawdown, 1 year (smaller is calmer)-40.7%
LiquidityWeak
12/100
Thinly traded: prices can jump and exits can be hard.
See the numbers →
Avg daily value traded0.02M USD
Zero-volume days36.7%
IncomeNone
–/100
Pays no dividend.
See the numbers →
Years with dividends0
Price-based X-Ray. The fundamental X-Ray (financial health, valuation, growth, fair value) is available for US stocks today. It will follow for UK when fundamentals data for this market is added. All UK stocks.
52-wk range 0.568 – 6.490Daily closes, split-adjusted
Signals
50-day average4.583
200-day average2.722
Golden/death cross (60d)None
New 52-week highNo
Bullish RSI divergenceNo
Average daily range (ATR)0.276
Technical summary
Daily
Bearish
4 bullish · 2 neutral · 10 bearish
Weekly
Neutral
6 bullish · 1 neutral · 5 bearish
Monthly
Strongly bullish
7 bullish · 1 neutral · 0 bearish
Moving averages (daily)
SMA 10
3.89
Bearish
EMA 10
3.96
Bearish
SMA 20
4.37
Bearish
EMA 20
4.20
Bearish
SMA 50
4.58
Bearish
EMA 50
4.38
Bearish
SMA 100
4.52
Bearish
EMA 100
4.03
Bearish
SMA 200
2.72
Bullish
EMA 200
3.20
Bullish
Oscillators (daily)
RSI (14)
32.87
Neutral
MACD (12, 26)
-0.27
Bearish
Momentum (12)
-26.98
Bearish
Stochastic %K (14)
0.00
Bullish
Williams %R (14)
-100.0
Bullish
CCI (20)
-85.35
Neutral
Pivot points (classic, last session)
S3
3.35
S2
3.51
S1
3.60
Pivot
3.76
R1
3.85
R2
4.01
R3
4.10
Signals describe what the chart is doing, not what to do. Moving averages: price above the average is bullish. Oscillators use the usual thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20; MACD and momentum above zero are bullish). Weekly and monthly views use closing prices only.
Prices are end-of-day closes in USD. Educational only, not financial advice.
